Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
ARWRArrowhead Pharmaceuticals | $2.74bn | n/a | n/a |
CGONCG Oncology | $2.73bn | n/a | n/a |
MLTXMoonLake Immunotherapeutics | $2.71bn | n/a | n/a |
SMMTSummit Therapeutics | $2.71bn | n/a | n/a |
MRUSMerus NV | $2.64bn | n/a | n/a |
JANXJanux Therapeutics | $2.45bn | n/a | n/a |
BLTEBelite Bio | $2.34bn | n/a | n/a |
CLDXCelldex Therapeutics | $2.34bn | n/a | n/a |
RYTMRhythm Pharmaceuticals | $2.33bn | n/a | n/a |
DICEDice Therapeutics | $2.27bn | n/a | n/a |
GERNGeron | $2.22bn | n/a | n/a |
ARVNArvinas | $2.21bn | n/a | n/a |
DNLIDenali Therapeutics | $2.20bn | n/a | n/a |
PTCTPTC Therapeutics | $2.19bn | n/a | n/a |
VERAVera Therapeutics | $2.16bn | n/a | n/a |
DYNDyne Therapeutics | $2.13bn | n/a | n/a |
APGEApogee Therapeutics | $2.12bn | n/a | n/a |
GHGuardant Health | $2.11bn | n/a | n/a |
KROSKeros Therapeutics | $2.09bn | n/a | n/a |
TGTXTG Therapeutics | $2.08bn | 157.86 | n/a |